EPO Patents = 6

Trademarks = 1

Forward Citations = 0

Loading Chart...

21 inventors (with patents filed for the assignee):

Jai Hee Moon (3 out of 5 patents)

Seung Woo Hong (3 out of 22 patents)

Jae Sik Shin (3 out of 5 patents)

4. Dong Hoon Jin (3 out of 5 patents)

5. Seul Gee Lee (2 out of 32 patents)

6. Eun Young Lee (2 out of 61 patents)

7. Seung Mi Kim (2 out of 3 patents)

8. Dae Hee Lee (2 out of 16 patents)

9. Hyunho Lee (1 out of 296 patents)

10. HyoJin Kim (1 out of 20 patents)

11. Hyebin Park (1 out of 4 patents)

12. Yong Sang Hong (1 out of 2 patents)

13. Joseph Kim (1 out of 3 patents)

14. Chun-Ho Park (1 out of 5 patents)

15. Seung-Woo Hong (1 out of 3 patents)

4 patents: Sort by Forward Citations

1. 11946934 - Biomarker for predicting the sensitivity to a protein kinase inhibitor and a use thereof (2024-04-02),

2. 11447500 - Thienopyridine derivatives and pharmaceutical composition comprising same (2022-09-20),

3. 11186873 - Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET) (2021-11-30),

4. 11008622 - Biomarker for predicting sensitivity to EGFR-targeting agent, and use thereof (2021-05-18),

Wellmarker Bio Co., Ltd. is a leading biotechnology company specializing in the development of innovative diagnostic solutions for the healthcare industry. With a focus on precision medicine, our cutting-edge technologies aim to improve patient outcomes and enhance the quality of healthcare delivery. Our team of experts is dedicated to advancing medical research and providing reliable diagnostic tools for a wide range of medical conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#677 in Seoul

#2,089 in South Korea

Seoul, South Korea

Wellmarker Bio Co., Ltd.